kth.sePublications KTH
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Advances in near-infrared responsive functional nanocomposites for bioimaging and antitumor research
College of Biological and Chemical Engineering, Qilu Institute of Technology, Jinan 250200, PR China.
College of Biological and Chemical Engineering, Qilu Institute of Technology, Jinan 250200, PR China.
College of Biological and Chemical Engineering, Qilu Institute of Technology, Jinan 250200, PR China.
College of Biological and Chemical Engineering, Qilu Institute of Technology, Jinan 250200, PR China.
Show others and affiliations
2025 (English)In: Journal of Controlled Release, ISSN 0168-3659, E-ISSN 1873-4995, Vol. 384, article id 113904Article, review/survey (Refereed) Published
Abstract [en]

Malignant tumors endanger human health, and their characteristics make treatment difficult. Near-infrared (NIR) light has become an ideal choice for biotherapy because it offers good penetrability and low damage. In recent years, NIR-based photothermal therapy, photodynamic therapy, photochemotherapy, and multimodal combination therapy have been developing rapidly, and the corresponding functional nanomaterials have been emerging. This review summarizes advances in NIR-triggered functional nanomaterials in tumor therapy, involving therapeutic reagent applications and synergistic and combined therapeutic systems. The nanomaterials have obvious advantages, such as the excellent performance of photothermal therapy- and photodynamic therapy-related nanomaterials, and multifunctional nanoplatforms capable of integrating multiple therapies. However, they face many challenges, such as the limitations of individual therapies and technical difficulties in the combined applications. In the future, we should focus on optimizing the materials, evaluating the combined therapeutic mechanism, innovating the technology and promoting clinical translation. The nanomaterials are expected to become the key means of clinical oncology treatment, bringing hope to overcome the malignant tumors.

Place, publisher, year, edition, pages
Elsevier BV , 2025. Vol. 384, article id 113904
Keywords [en]
Bioimaging, Biomolecule delivery, Functional nanomaterials, Multi-mode combination therapy, NIR, PDT agents, PTT agents, Theranostics
National Category
Pharmacology and Toxicology Nanotechnology for/in Life Science and Medicine
Identifiers
URN: urn:nbn:se:kth:diva-368514DOI: 10.1016/j.jconrel.2025.113904ISI: 001512643200002PubMedID: 40499761Scopus ID: 2-s2.0-105007978583OAI: oai:DiVA.org:kth-368514DiVA, id: diva2:1989774
Note

QC 20250818

Available from: 2025-08-18 Created: 2025-08-18 Last updated: 2025-09-26Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Yu, Dongkun

Search in DiVA

By author/editor
Yu, Dongkun
By organisation
Bio-Opto-Nano Physics
In the same journal
Journal of Controlled Release
Pharmacology and ToxicologyNanotechnology for/in Life Science and Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 53 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf